All Episodes

Gastrointestinal Injury Caused by Aspirin or Clopidogrel Monotherapy Versus Dual Antiplatelet Therapy

2021 Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Real World Analysis of Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation- a RWE

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression

Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy

Randomized Trial of Metoprolol in Patients with Obstructive Hypertrophic Cardiomyopathy

Dabigatran versus Warfarin on Cognitive Outcomes in Non- valvular Atrial Fibrillation: Results of the GIRAF Trial

AXIOMATIC-TKR Trial

Empagliflozin in Patients Hospitalized for Acute Heart Failure – EMPULSE trial

Daily Oral PCSK9 Inhibitor Encouraging in Phase 1 Trials

Real-World’ Prolonged DAPT Use Associated With Reduced Benefits, and Greater Harm

Rapid and Sustained Reversal of Ticagrelor–Intervention Trial called REVERSE-IT

Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation

Diuretic vs. placebo in intermediate-risk acute pulmonary embolism: a randomized clinical trial

Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR

Association of Statin Therapy Initiation with Diabetes Progression

Metoprolol in Critically Ill Patients With COVID-19

Fineronone improves CV outcomes in T2DM with CKD 2-4 stages

Triglycerides and Residual Atherosclerotic Risk in participants with normal LDL-C levels

Antihypertensives and Statin Therapy for Primary Stroke Prevention (A Secondary Analysis of the HOPE-3 Trial).

Highlights of ESC Congress 2021: TOMAHAWK Trial

Highlights of ESC Congress 2021: STEP Study

Highlights of ESC Congress 2021: Master DAPT

Highlights of ESC Congress 2021: Emperor Preserved HF

Diabetes Duration Linked to Increasing Heart Failure Risk

Meta-Analysis of Duration of Dual Antiplatelet Therapy in Acute Coronary Syndrome Treated With Coronary Stenting

Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial

Highlights of ESC HF 2021 - Insights from Augustus Trial

Highlights of ESC HF 2021 - AFFIRM-AHF-based multinational cost-effectiveness analysis of intravenous ferric carboxymaltose for the treatment of iron deficiency in an acute heart failure setting

Highlights of ESC HF 2021 - Insights from the VICTORIA trial (VerICiguaT global study in subjects with HFrEF)

Highlights of ESC HF 2021 - Insights from the GALACTIC-HF Trial

Highlights of ESC HF 2021 - Which Beta Blocker in HFmrEF?

PARADISE MI

THE ADAPTABLE STUDY

ATLANTIS

LAAOS 3

The Value of High-Sensitivity Troponin in the Era of COVID-19

Death and MI following initial revascularization versus optimal medical therapy in chronic coronary syndrome: A systemic review & Meta-analysis of RCT

Macitentan Triple combination therapy in Pulmonary Arterial Hypertension: Real World evidence from Opus Registry

The Future of Aspirin Therapy in Cardiovascular Disease